Double-blind, randomized, controlled, pilot study comparing classic ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis

Journal of Clinical Rheumatology

Volumn 17, Issue 4, 2011, Pages 185-192

  Furst, Daniel E ^a   Manorama M Venkatraman, ^b   Mary McGann, ^e   P Ram Manohar, ^c   Cathryn Booth LaForce, ^a   Reshmi Sarin, ^c   P g Sekar, ^e   K g Raveendran, ^c   Anita Mahapatra, ^d   Jidesh Gopinath, ^c   Kumar, P R Krishna ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Ayurvedic Trust   (India)

^d KEM HOSPITAL   (India)

^e NONE

Author keywords

Ayurvedic; Controlled trial; Methotrexate; Rheumatoid arthritis

Indexed keywords

AYURVEDIC DRUG; METHOTREXATE;

ABDOMINAL PAIN; ADULT; ANEMIA; ARTICLE; AYURVEDA; CLINICAL ARTICLE; COMMON COLD; CONSTIPATION; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DYSGEUSIA; DYSPEPSIA; EAR NOSE THROAT DISEASE; EYE DISEASE; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HAIR LOSS; HEADACHE; HEMORRHOID; HUMAN; INFECTION; LUNG DISEASE; MALE; MENSTRUATION DISORDER; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL PAIN; NAUSEA; NEUROLOGIC DISEASE; PILOT STUDY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RHEUMATOID ARTHRITIS; SKIN DISEASE; STOMATITIS; THORAX PAIN; TOOTH DISEASE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; UROGENITAL TRACT DISEASE; VERTIGO;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEDICINE, AYURVEDIC; METHOTREXATE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80051787796     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31821c0310     Document Type: Article

References (24)

1. Pincus T, Callahan LF. Early mortality in RA predicted by poor clinical status. Bull Rheum Dis. 1992;41:1-4.
2. Klippel JH. Primer on the Rheumatic Diseases. Arthritis Foundation; 1997. p. 155-174.
3. Haagsma CJ, van Riel PL, DeJong AJ, et al. Combination of sulfasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52-week clinical trial. Br J Rheumatol. 1997;36:1082-1088.
4. Visser GJ, Peters L, Rasker JJ. Rheumatologists and their patients who seek alternative care. Br J Rheumatol. 1992;31:485-490.
5. Available at: http://pqasb.pqarchiver.com/washingtonpost/access/ 1005700131.
6. Available at: http://www.pbs.org/frontlineworld/stories/india701/.
7. Ulrich-Merzenich G, Kraft K, Singh LM. Rheumatic diseases in Ayurveda: a historical perspective. Arthritis Rheum. 1999;42: 1554-1557.
8. Mishra L, Singh BB, Dagenais S. Ayurveda: a historical perspective and principles of the traditional healthcare system in India. Altern Ther Health Med. 2001;7:36-42. (Pubitemid 32201794)
9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/.
10. Hardy M, Coulter I, Venuturupalli S, et al. Ayurvedic interventions for diabetes mellitus: a systematic review. Evid Rep Technol Assess (Summ). 2001;(41):2p.
11. George JC. Ray of hope. WHO Bulletin. 1985;112-116.
12. Venkatraman M, Assefi N. Ayurveda: general principles and treatment of rheumatoid arthritis. Altern Med Alert. 2002;5:144-147.
13. Furst DE, Venkatraman MM, Krishna Swamy BG, et al. Well controlled, double-blind, placebo-controlled trials of classical Ayurvedic treatment are possible in rheumatoid arthritis. Ann Rheum Dis. 2010.
14. Van Gestel AM, Anderson JJ, van Riel PL, et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. J Rheumatol. 1999;26:705-711. (Pubitemid 29125596)
15. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995;38:727-735.
16. Lubeck D. Health-related quality of life measurements and studies in rheumatoid arthritis. Am J Manag Care. 2002;8:811-820.
17. Park J, Ernst E. Ayurvedic medicine for rheumatoid arthritis: a systematic review. Semin Arthritis Rheum. 2005;34:705-713.
18. Chopra A, Lavin P, Patwardhan B, et al. Randomized double blind trial of an Ayurvedic plant derived formulation for treatment of rheumatoid arthritis. J Rheumatol. 2000;27:1362-1365.
19. Kulkarni RR, Patki PS, Log VP, et al. Efficacy of an Ayurvedic formulation in rheumatoid arthritis: a double blind, placebo controlled, cross-over study. Indian J Pharmacol. 1992;24:98-101.
20. Sander O, Herborn G, Rau R. Is H15 (extract of Boswellia serrata, ''incense'') an efficient supplementation to established drug therapy in RA? Results of a double blind pilot trial. J Rheumatol. 1998;57:11-16. (Pubitemid 28164207)
21. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12. (Pubitemid 26120810)
22. Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, et al. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum. 2006;54:1390-1400.
23. Schiff M, Keiserman M, Codding C, et al. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. Ann Rheum Dis. 2008;67:1096-1103.
24. Kay J, Matteson EL, Dasgupta B, et al. Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum. 2008;58:964-975. (Pubitemid 351563997)